Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2xkf | BX1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
2xkf | BX1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 1.000 | |
2xkd | T3M | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.594 | |
2xke | WI2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.591 | |
2xk8 | 5R1 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.586 | |
2wqo | VGK | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.582 | |
2xk7 | 30E | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.582 | |
2xkc | 4VQ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.576 | |
2z2w | 770 | Wee1-like protein kinase | 2.7.10.2 | 0.575 | |
2xk4 | OL2 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.573 | |
2in6 | 839 | Wee1-like protein kinase | 2.7.10.2 | 0.555 | |
2yac | 937 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.555 | |
2owb | 626 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.551 | |
1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.541 | |
2xnp | WCX | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.533 | |
2w5a | ADP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.522 | |
4j53 | 1J4 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.522 | |
2xnm | WGZ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.521 | |
2io6 | 330 | Wee1-like protein kinase | 2.7.10.2 | 0.520 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.520 | |
2xk6 | EQH | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.519 | |
3biz | 61E | Wee1-like protein kinase | 2.7.10.2 | 0.519 | |
3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.518 | |
4afe | GGY | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.508 | |
2xk3 | XK3 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.507 | |
4a4o | 664 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.502 | |
4j52 | 1J3 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.502 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.499 | |
3bi6 | 396 | Wee1-like protein kinase | 2.7.10.2 | 0.495 | |
2uag | UMA | UDP-N-acetylmuramoylalanine--D-glutamate ligase | 6.3.2.9 | 0.486 | |
4f1m | ACP | Probable serine/threonine-protein kinase roco4 | 2.7.11.1 | 0.485 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
4a4x | JUP | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.481 | |
2rku | R78 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.478 | |
3cqe | P91 | Wee1-like protein kinase | 2.7.10.2 | 0.478 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.477 | |
4a4l | 939 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.475 | |
2ejz | SAH | Diphthine synthase | / | 0.473 | |
1t57 | FMN | Conserved protein | / | 0.472 | |
2vet | UMP | Thymidylate synthase | / | 0.466 | |
3h1v | TK1 | Glucokinase | 2.7.1.2 | 0.464 | |
2a19 | ANP | Interferon-induced, double-stranded RNA-activated protein kinase | 2.7.11.1 | 0.463 | |
2ed3 | SAH | Diphthine synthase | / | 0.463 | |
1qoq | IGP | Tryptophan synthase alpha chain | / | 0.462 | |
3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.462 | |
4twn | B96 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.462 | |
2zev | B71 | Geranylgeranyl pyrophosphate synthase | / | 0.457 | |
3c1o | NAP | Eugenol synthase | / | 0.457 | |
4ajd | F04 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.457 | |
1yc2 | NAD | NAD-dependent protein deacylase 2 | / | 0.456 | |
4bfu | ZVU | Pantothenate kinase | 2.7.1.33 | 0.456 | |
5dp2 | NAP | CurF | / | 0.456 | |
2xno | ED8 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.455 | |
1g63 | FMN | Epidermin decarboxylase | 4.1.1 | 0.452 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.452 | |
2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.452 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.450 | |
4b6l | 9ZP | Serine/threonine-protein kinase PLK3 | 2.7.11.21 | 0.450 | |
4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4f3g | KAI | Glutamate receptor 3 | / | 0.449 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.448 | |
5bn3 | ADP | V-type ATP synthase alpha chain | / | 0.448 | |
5bn3 | ADP | NEQ263 | / | 0.448 | |
1c3x | 8IG | Purine nucleoside phosphorylase | 2.4.2.1 | 0.447 | |
1eji | THF | Serine hydroxymethyltransferase, cytosolic | / | 0.447 | |
2gq3 | COA | Malate synthase G | / | 0.447 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.447 | |
1cqp | 803 | Integrin alpha-L | / | 0.446 | |
1dr3 | TAP | Dihydrofolate reductase | 1.5.1.3 | 0.446 | |
2obx | INI | 6,7-dimethyl-8-ribityllumazine synthase 2 | 2.5.1.78 | 0.446 | |
3g4i | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.446 | |
4iql | FMN | Enoyl-(Acyl-carrier-protein) reductase II | / | 0.446 | |
1xdd | AAY | Integrin alpha-L | / | 0.445 | |
3jyo | NAD | Quinate/shikimate dehydrogenase (NAD(+)) | / | 0.445 | |
4bub | ADP | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--LD-lysine ligase | / | 0.445 | |
4djw | 0KP | Beta-secretase 1 | 3.4.23.46 | 0.445 | |
2xvw | 9NR | Serum albumin | / | 0.444 | |
3c35 | KAI | Glutamate receptor ionotropic, kainate 1 | / | 0.444 | |
4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.444 | |
4htx | 19F | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.444 | |
2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.443 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.443 | |
1s3u | TQD | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1t13 | INI | 6,7-dimethyl-8-ribityllumazine synthase 2 | / | 0.442 | |
2cle | F6F | Tryptophan synthase alpha chain | / | 0.442 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.442 | |
3af0 | GDP | Pantothenate kinase | 2.7.1.33 | 0.442 | |
3fhx | PLP | Pyridoxal kinase | 2.7.1.35 | 0.442 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.442 | |
3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.442 | |
1t4c | COA | Formyl-CoA:oxalate CoA-transferase | / | 0.441 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.441 | |
3dyl | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
3sl6 | JN8 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.441 | |
3sni | 546 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 | |
5k2c | ZMA | Adenosine receptor A2a | / | 0.441 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.441 | |
2a94 | AP0 | L-lactate dehydrogenase | 1.1.1.27 | 0.440 | |
2w6c | BM4 | Acetylcholinesterase | 3.1.1.7 | 0.440 | |
2xvv | 9DN | Serum albumin | / | 0.440 | |
4fcd | 0T6 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.440 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4zir | ANP | Energy-coupling factor transporter ATP-binding protein EcfA2 | 3.6.3 | 0.440 | |
4zir | ANP | Energy-coupling factor transporter ATP-binding protein EcfA1 | / | 0.440 | |
5iu8 | 6DZ | Adenosine receptor A2a | / | 0.440 |